1. Home /
  2. Executive Interview

Executive Interview

Shares of Salesforce.com Can Trade Higher Into the Summer Months

Let's see what strategy makes sense today.

Vaccine Maker Emergent BioSolutions Could Surge Higher in the Months Ahead

EBS has been in an uptrend for a long time.

Seattle Genetics Soars on Cancer Drugs: Here's How to Play the Stock

This biotech is on the front lines of oncology treatments.

How to Trade Estee Lauder Now

Let's check out the charts and indicators of EL.

Clorox Climbs and Could Clean Up Even More in the Months Ahead

Trading volume in the disinfectant maker's shares has been very active since February, which coincides with rising coronavirus fears.

Juniper Networks Could See a Deeper Retracement Ahead

Avoid the long side for now.

Align Technologies Could Push Higher but the Volume Pattern Doesn't Impress Me

I don't see clear signs of aggressive buying.

Keeping Risk in Mind, Traders Could Buy Automatic Data Processing Closer to $140

CEO Rodriguez said he's seeing some indications that the economy has bottomed and is getting a general feeling that the worst is now behind us.

Campbell Soup: Stock Up or Let It Simmer?

Consumers are heating up the demand for CPB's products.

Yum Brands Could Creep Higher but Chart Resistance Could Become an Issue

There are positive technical signals for the restaurant opeator's shares, but further gains could run into a ceiling.